Norovirus Infections

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-04-29
Clinical Trial Update: A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old [Phase 1]
This Phase 1 clinical trial evaluates an oral norovirus G1.1/G2.4 vaccine in healthy adults aged 18-80, sponsored by Vaxart.